Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
Cash Flows From Operating Activities | |||||
Net Income | -38,391 | -20,977 | -16,941 | -66,480 | -57,530 |
Depreciation Amortization | 8,687 | 5,977 | 2,893 | 12,620 | 9,470 |
Accounts receivable | -4,384 | -2,182 | -2,439 | -7,041 | N/A |
Accounts payable and accrued liabilities | -2,692 | -4,992 | -2,868 | 1,443 | N/A |
Other Working Capital | -584 | -3,266 | -4,917 | -20,180 | -11,270 |
Other Operating Activity | 22,570 | 20,407 | 18,713 | 17,088 | 5,580 |
Operating Cash Flow | $-14,794 | $-5,033 | $-5,559 | $-62,550 | $-53,750 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -1,306 | -5,493 | -7,389 | -1,377 | N/A |
PPE Investments | -11,575 | -5,973 | -3,724 | -12,470 | -7,370 |
Purchase Of Investment | -2,450 | -2,450 | -2,450 | -2,450 | N/A |
Other Investing Activity | 0 | 0 | 0 | -3 | 9,610 |
Investing Cash Flow | $-15,331 | $-13,916 | $-13,563 | $-16,300 | $2,240 |
Cash Flows From Financing Activities | |||||
Debt Repayment | -2,462 | -1,724 | -913 | -5,320 | N/A |
Common Stock Issued | 26,567 | 15,105 | 9,996 | 29,295 | N/A |
Other Financing Activity | 0 | 0 | 0 | -5 | 21,060 |
Financing Cash Flow | $24,105 | $13,381 | $9,083 | $23,970 | $21,060 |
Exchange Rate Effect | 2,383 | 1,297 | 324 | 750 | 100 |
Beginning Cash Position | 47,011 | 47,011 | 47,011 | 101,130 | 101,130 |
End Cash Position | 43,374 | 42,740 | 37,296 | 47,010 | 70,790 |
Net Cash Flow | $-3,637 | $-4,271 | $-9,715 | $-54,120 | $-30,340 |
Free Cash Flow | |||||
Operating Cash Flow | -14,794 | -5,033 | -5,559 | -62,550 | -53,750 |
Capital Expenditure | -11,575 | -5,973 | -3,724 | -12,475 | N/A |
Free Cash Flow | -26,369 | -11,006 | -9,283 | -75,025 | -53,750 |